Moreover, Martins and colleagues demonstrated the tumor suppressor activity of PLCE1 in KRAS-mutated tumor models [44] while analysis of single-cell data from Lee et al. [35] reinforced the detectability of PLCE1 in both epithelial and stromal cells, supporting a tumor-specific downregulation. The gene discussed is KRAS; the disease is neoplasm.